These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
230 related items for PubMed ID: 23084642
1. Soy protein with or without isoflavones failed to preserve bone density in gonadal hormone-deficient male rat model of osteoporosis. Juma SS, Ezzat-Zadeh Z, Khalil DA, Hooshmand S, Akhter M, Arjmandi BH. Nutr Res; 2012 Sep; 32(9):694-700. PubMed ID: 23084642 [Abstract] [Full Text] [Related]
2. Soy affects trabecular microarchitecture and favorably alters select bone-specific gene expressions in a male rat model of osteoporosis. Soung DY, Devareddy L, Khalil DA, Hooshmand S, Patade A, Lucas EA, Arjmandi BH. Calcif Tissue Int; 2006 Jun; 78(6):385-91. PubMed ID: 16830200 [Abstract] [Full Text] [Related]
3. Bone-sparing effect of soy protein in ovarian hormone-deficient rats is related to its isoflavone content. Arjmandi BH, Birnbaum R, Goyal NV, Getlinger MJ, Juma S, Alekel L, Hasler CM, Drum ML, Hollis BW, Kukreja SC. Am J Clin Nutr; 1998 Dec; 68(6 Suppl):1364S-1368S. PubMed ID: 9848500 [Abstract] [Full Text] [Related]
4. Soy isoflavones may protect against orchidectomy-induced bone loss in aged male rats. Khalil DA, Lucas EA, Smith BJ, Soung DY, Devareddy L, Juma S, Akhter MP, Recker R, Arjmandi BH. Calcif Tissue Int; 2005 Jan; 76(1):56-62. PubMed ID: 15549639 [Abstract] [Full Text] [Related]
5. Soy moderately improves microstructural properties without affecting bone mass in an ovariectomized rat model of osteoporosis. Devareddy L, Khalil DA, Smith BJ, Lucas EA, Soung do Y, Marlow DD, Arjmandi BH. Bone; 2006 May; 38(5):686-93. PubMed ID: 16406762 [Abstract] [Full Text] [Related]
7. The effects of fructo-oligosaccharides in combination with soy protein on bone in osteopenic ovariectomized rats. Devareddy L, Khalil DA, Korlagunta K, Hooshmand S, Bellmer DD, Arjmandi BH. Menopause; 2006 May; 13(4):692-9. PubMed ID: 16837891 [Abstract] [Full Text] [Related]
9. Effects of soy isoflavone and/or estrogen treatments on bone metabolism in ovariectomized rats. Kim MS, Lee YS. J Med Food; 2005 May; 8(4):439-45. PubMed ID: 16379553 [Abstract] [Full Text] [Related]
10. Lasofoxifene (CP-336,156), a selective estrogen receptor modulator, prevents bone loss induced by aging and orchidectomy in the adult rat. Ke HZ, Qi H, Crawford DT, Chidsey-Frink KL, Simmons HA, Thompson DD. Endocrinology; 2000 Apr; 141(4):1338-44. PubMed ID: 10746637 [Abstract] [Full Text] [Related]
15. Dietary soy protein and isoflavones have no significant effect on bone and a potentially negative effect on the uterus of sexually mature intact Sprague-Dawley female rats. Nakai M, Cook L, Pyter LM, Black M, Sibona J, Turner RT, Jeffery EH, Bahr JM. Menopause; 2005 Apr; 12(3):291-8. PubMed ID: 15879918 [Abstract] [Full Text] [Related]
17. Dietary soy protein maintains some indices of bone mineral density and bone formation in aged ovariectomized rats. Blum SC, Heaton SN, Bowman BM, Hegsted M, Miller SC. J Nutr; 2003 May; 133(5):1244-9. PubMed ID: 12730404 [Abstract] [Full Text] [Related]
18. Prostaglandin E2 administration prevents bone loss induced by orchidectomy in rats. Li M, Jee WS, Ke HZ, Tang LY, Ma YF, Liang XG, Setterberg RB. J Bone Miner Res; 1995 Jan; 10(1):66-73. PubMed ID: 7747632 [Abstract] [Full Text] [Related]
20. The effect of soybean protein on bone loss in a rat model of postmenopausal osteoporosis. Harrison E, Adjei A, Ameho C, Yamamoto S, Kono S. J Nutr Sci Vitaminol (Tokyo); 1998 Apr; 44(2):257-68. PubMed ID: 9675706 [Abstract] [Full Text] [Related] Page: [Next] [New Search]